Display options
Share it on

Exp Ther Med. 2018 Aug;16(2):595-602. doi: 10.3892/etm.2018.6252. Epub 2018 Jun 06.

MicroRNA-199a-5p aggravates primary hypertension by damaging vascular endothelial cells through inhibition of autophagy and promotion of apoptosis.

Experimental and therapeutic medicine

Xintao Tian, Chunpeng Yu, Lei Shi, Dan Li, Xiaoxue Chen, Di Xia, Jingwei Zhou, Wanqun Xu, Chengtai Ma, Lihua Gu, Yi An

Affiliations

  1. Department of Emergency Internal Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
  2. Department of Intervention, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.
  3. Department of Cardiovascular Medicine, Laoshan District of The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, P.R. China.

PMID: 30116316 PMCID: PMC6090226 DOI: 10.3892/etm.2018.6252

Abstract

The present study investigated the expression of microRNA (miRNA or miR)-199a-5p in the peripheral blood of patients with primary hypertension, and examined its mechanism of action in vascular endothelial cell injury induced by hypertension. A total of 57 patients with primary hypertension, who were treated at the Affiliated Hospital of Qingdao University (Qingdao, China) between December 2014 and November 2015 were included in the present study. Peripheral blood was collected from all patients. The expression of miR-199a-5p was measured using reverse-transcription quantitative polymerase chain reaction analysis. Human umbilical vein endothelial cells (HUVECs) were divided into negative control, miR-199a-5p mimics and rescue (co-transfected with miR-199a-5p mimics and inhibitor) groups. After transfection, the proliferation and apoptosis of HUVECs were evaluated by a Cell Counting Kit-8 assay, a bromodeoxyuridine incorporation assay and flow cytometry. Western blot analysis was used to determine the expression of proteins involved in autophagy-associated and adenosine monophosphate kinase (AMPK)/unc-51 like autophagy activating kinase 1 (ULK1) signaling pathways. Laser scanning confocal microscopy and electron microscopy were used to observe the autophagy of HUVECs. The expression of miR-199a-5p was elevated in peripheral blood of patients with hypertension, and was correlated with the progression of hypertension. Overexpression of miR-199a-5p inhibited the proliferation and promoted the apoptosis of HUVECs. Upon expression of miR-199a-5p, the transition between microtubule-associated proteins 1A/1B light chain 3B (LC3B)I and LC3BII proteins was inhibited, the expression of p62 protein was upregulated. In addition, miR-199a-5p decreased the numbers of autophagosomes and autolysosomes in HUVECs. The present study demonstrated that expression of miR-199a-5p is positively correlated with the severity of hypertension. Expression of miR-199a-5p aggravated vascular endothelial injury by inhibiting autophagy and promoting the apoptosis of HUVECs via downregulation of the AMPK/ULK1 signaling pathway.

Keywords: apoptosis; autophagy; microRNA-199a-5p; primary hypertension; vascular endothelial cell injury

References

  1. Eur Heart J. 2017 Feb 14;38(7):524-528 - PubMed
  2. J Biol Chem. 2015 Mar 13;290(11):7067-86 - PubMed
  3. Apoptosis. 2016 Jan;21(1):69-84 - PubMed
  4. Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):8-13 - PubMed
  5. Mol Med Rep. 2016 Jul;14(1):22-32 - PubMed
  6. Onco Targets Ther. 2016 Jun 16;9:3579-88 - PubMed
  7. Methods. 2001 Dec;25(4):402-8 - PubMed
  8. J Hypertens. 2016 Aug;34(8):1489-91 - PubMed
  9. Curr Pharmacol Rep. 2016 Apr;2(2):91-101 - PubMed
  10. Inflamm Res. 2016 Oct;65(10):803-13 - PubMed
  11. J Vasc Surg. 2016 Nov;64(5):1468-1477 - PubMed
  12. Cell Death Differ. 2017 Jul;24(7):1205-1213 - PubMed
  13. Cell Physiol Biochem. 2016;38(5):1743-51 - PubMed
  14. J Hypertens. 2016 Aug;34(8):1492-3 - PubMed
  15. PLoS One. 2018 Apr 5;13(4):e0195340 - PubMed
  16. Hypertension. 2016 Aug;68(2):289-96 - PubMed
  17. Clin Chem Lab Med. 2017 Jan 1;55(1):38-46 - PubMed
  18. Mol Med Rep. 2016 Jun;13(6):5241-7 - PubMed
  19. J Transl Med. 2016 Jul 02;14(1):200 - PubMed
  20. Biochem Biophys Res Commun. 2016 May 13;473(4):859-866 - PubMed
  21. Tumour Biol. 2016 Jul;37(7):9527-34 - PubMed
  22. Onco Targets Ther. 2016 May 04;9:2667-74 - PubMed
  23. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):258-267 - PubMed
  24. Cardiovasc Res. 2016 Aug 1;111(3):163-4 - PubMed
  25. Sci Rep. 2015 Oct 01;5:14728 - PubMed
  26. Onco Targets Ther. 2016 Jun 15;9:3555-63 - PubMed
  27. Cell Prolif. 2016 Aug;49(4):484-93 - PubMed
  28. Biochem Biophys Res Commun. 2012 Jul 13;423(4):826-31 - PubMed
  29. Trends Cardiovasc Med. 2016 Jul;26(5):407-19 - PubMed
  30. Am J Physiol Heart Circ Physiol. 2015 Oct;309(8):H1303-13 - PubMed

Publication Types